Niagen Bioscience, Inc. (NAGE) stock
NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$1.94−0.10 (-4.90%)
Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –
Niagen Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Niagen Bioscience's market cap was $165.31M on Nov 11, 2026, against $539.16M a year earlier. Over the last 5 years it ranged from $83.83M to $1.13B, with a median of $224.71M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $165.31M | -67.4% |
| 2025 | Dec 31, 2025 | $506.50M | +25.6% |
| 2024 | Dec 31, 2024 | $403.32M | +276.5% |
| 2023 | Dec 29, 2023 | $107.12M | -6.5% |
| 2022 | Dec 30, 2022 | $114.52M | -55.0% |
| 2021 | Dec 31, 2021 | $254.67M | +86048.9% |
| 2020 | Dec 31, 2020 | $295.62K | +15.5% |
| 2019 | Dec 31, 2019 | $255.94K | +35.9% |
| 2018 | Dec 31, 2018 | $188.37K | -99.9% |
| 2017 | Dec 29, 2017 | $280.18M | +125.5% |
| 2016 | Dec 30, 2016 | $124.27M | -4.2% |
| 2015 | Dec 31, 2015 | $129.67M | +40.7% |
| 2014 | Dec 31, 2014 | $92.15M | -34.2% |
| 2013 | Dec 31, 2013 | $140.05M | +188.3% |
| 2012 | Dec 31, 2012 | $48.57M | +21.1% |
| 2011 | Dec 30, 2011 | $40.12M | – |
See a number that looks wrong?